MedTrace Logo

Pioglitazone on Cardiac Function and Large Arteries (PICCOLA Study)

NCT00485056 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2016-08-09

No results posted yet for this study

Summary

This study aims to use a novel, sensitive, non-invasive scanning technique to investigate the effects of insulin-sensitizing agent pioglitazone, on heart and artery function.

Conditions

Interventions

DRUG

Pioglitazone

45mgs daily

Sponsors & Collaborators

  • Imperial College London

    lead OTHER

Principal Investigators

  • Alun D Hughes, phd · Imperial College London

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2010-04-30
Completion
2010-04-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00485056 on ClinicalTrials.gov